Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. More Details
Adequate balance sheet with moderate growth potential.
Share Price & News
How has Novanta's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1GSN has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 1GSN exceeded the German Electronic industry which returned -8.1% over the past year.
Return vs Market: 1GSN exceeded the German Market which returned -6.6% over the past year.
Price Volatility Vs. Market
How volatile is Novanta's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Novanta undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1GSN (€93) is trading above our estimate of fair value (€35.53)
Significantly Below Fair Value: 1GSN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1GSN is poor value based on its PE Ratio (91.4x) compared to the DE Electronic industry average (33x).
PE vs Market: 1GSN is poor value based on its PE Ratio (91.4x) compared to the German market (21.2x).
Price to Earnings Growth Ratio
PEG Ratio: 1GSN is poor value based on its PEG Ratio (3.3x)
Price to Book Ratio
PB vs Industry: 1GSN is overvalued based on its PB Ratio (8.8x) compared to the DE Electronic industry average (1.7x).
How is Novanta forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1GSN's forecast earnings growth (27.9% per year) is above the savings rate (0.2%).
Earnings vs Market: 1GSN's earnings (27.9% per year) are forecast to grow faster than the German market (25.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1GSN's revenue (5.1% per year) is forecast to grow slower than the German market (5.9% per year).
High Growth Revenue: 1GSN's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1GSN's Return on Equity is forecast to be high in 3 years time
How has Novanta performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1GSN has a large one-off loss of $15.4M impacting its July 3 2020 financial results.
Growing Profit Margin: 1GSN's current net profit margins (6.8%) are lower than last year (8.7%).
Past Earnings Growth Analysis
Earnings Trend: 1GSN has become profitable over the past 5 years, growing earnings by 18.5% per year.
Accelerating Growth: 1GSN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1GSN had negative earnings growth (-23.9%) over the past year, making it difficult to compare to the Electronic industry average (-42.2%).
Return on Equity
High ROE: 1GSN's Return on Equity (9.7%) is considered low.
How is Novanta's financial position?
Financial Position Analysis
Short Term Liabilities: 1GSN's short term assets ($310.4M) exceed its short term liabilities ($129.3M).
Long Term Liabilities: 1GSN's short term assets ($310.4M) exceed its long term liabilities ($299.9M).
Debt to Equity History and Analysis
Debt Level: 1GSN's debt to equity ratio (50.2%) is considered high.
Reducing Debt: 1GSN's debt to equity ratio has increased from 48.8% to 50.2% over the past 5 years.
Debt Coverage: 1GSN's debt is well covered by operating cash flow (43.3%).
Interest Coverage: 1GSN's interest payments on its debt are well covered by EBIT (8.8x coverage).
What is Novanta current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 1GSN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1GSN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 1GSN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1GSN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1GSN's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Matthijs Glastra (51 yo)
Mr. Matthijs Glastra has been the Chief Executive Officer and Director of Novanta Inc. (alternate name: GSI Group Inc.) since September 1, 2016 and was its Executive Officer since September 2012. Mr. Glast ...
CEO Compensation Analysis
Compensation vs Market: Matthijs's total compensation ($USD4.06M) is above average for companies of similar size in the German market ($USD2.89M).
Compensation vs Earnings: Matthijs's compensation has been consistent with company performance over the past year.
|CEO & Director||4.08yrs||US$4.06m||0.30% |
|Chief Financial Officer||9.58yrs||US$1.64m||0.45% |
|Chief Human Resources Officer||3.83yrs||US$806.42k||0.044% |
|VP, Corporate Controller & Chief Accounting Officer||9.17yrs||no data||0.038% |
|Executive Vice President of Strategy & Business Development||0.75yr||no data||no data|
|Group President of Photonics||4.25yrs||no data||no data|
|Group President of Precision Motion||4yrs||no data||no data|
|Group President of Minimally Invasive Surgery||2.5yrs||no data||no data|
|Corporate Finance Leader||no data||no data||no data|
Experienced Management: 1GSN's management team is considered experienced (4 years average tenure).
|CEO & Director||4.08yrs||US$4.06m||0.30% |
|Independent Chairman of the Board||10.25yrs||US$312.49k||1.88% |
|Independent Director||10.25yrs||US$202.49k||0.0028% |
|Independent Director||1.42yrs||US$121.40k||0.0014% |
|Independent Director||3.42yrs||US$187.49k||0.0028% |
|Independent Director||2.42yrs||US$187.49k||0.0028% |
|Independent Director||8.33yrs||US$197.47k||0.0028% |
|Independent Director||0.42yr||no data||no data|
Experienced Board: 1GSN's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Novanta Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Novanta Inc.
- Ticker: 1GSN
- Exchange: DB
- Founded: 1968
- Industry: Electronic Equipment and Instruments
- Sector: Tech
- Market Cap: US$3.893b
- Listing Market Cap: US$3.341b
- Shares outstanding: 35.16m
- Website: https://www.novanta.com
Number of Employees
- Novanta Inc.
- 125 Middlesex Turnpike
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NOVT||NasdaqGS (Nasdaq Global Select)||Yes||Common Shares||US||USD||Sep 1995|
|1GSN||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Sep 1995|
|0VAG||LSE (London Stock Exchange)||Yes||Common Shares||GB||USD||Sep 1995|
|NOVT N||BMV (Bolsa Mexicana de Valores)||Yes||Common Shares||MX||MXN||Sep 1995|
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/30 21:23|
|End of Day Share Price||2020/10/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.